A separate evolutionary analysis study that sequenced STICs, ovarian cancer, and metastases in nine patients found tumor-specific alterations in p53, BRCA1, BRCA2, or PTEN to be present in STICs [37]. Here, TP53 is linked to ovarian cancer.